Deutsche Bank downgrades HSBC to 'sell', prefers Barclays, RBS and Lloyds

Deutsche Bank’s top picks in order of preference are Barclays, RBS and Lloyds

Changes to US interest rate expectations are a headwind facing HSBC

HSBC Holdings PLC (LON:HSBA) shares declined on Monday as Deutsche Bank cut its recommendation to ‘sell’ and lowered its target price to 580p from 718p in a note on the European banking sector.  

Deutsche Bank said HSBC has been a relative outperformer in recent years despite a 16% fall in the shares since the start of 2018 but thinks there are significant headwinds arising that are not reflected in consensus forecasts or the share price.

READ: Deutsche Bank cuts target price on Lloyds, Barclays and RBS after 'annus horribilis'

In morning trading, HSBC shares were down 1.3% to 639p.

Headwinds include changes to US interest rate expectations, which has had an impact on the outlook for revenue growth.

Deutsche Bank still expects three rate rises in 2019-20, but the market is pricing in zero, which would represent a further 3% off earnings.

“We do not think consensus reflects this risk to earnings,” Deutsche Bank said.

Another headwind is in Hong Kong where Deutsche Bank analysts expect to see a 25% drop in house price from September 2018 to the end of 2019.

Deutsche Bank also sees associated income risks for China’s Bank of Communications, should assumptions for value-in-use change for HSBC's stake.

“This is an accounting rather than economic effect, but we do not think consensus reflects the risk of impairment to associate income, which would affect earnings and valuation multiples,” the investment bank said.

HSBC’s valuation is expensive compared to other US large caps, European banks and UK domestic lenders, Deutsche Bank added.

The bank has a dividend yield of 6% but Deutsche Bank said this does not rise over its forecast period and sees better opportunities for capital returns at Barclays PLC (LON:BARC), Royal Bank of Scotland Group PLC (LON:RBS) or even Standard Chartered PLC (LON:STAN).

Top picks Barclays, RBS and Lloyds 

Deutsche Bank’s top picks in order of preference are Barclays, RBS and Lloyds Banking Group PLC (LON:LLOY) with a ‘buy’ rating on all three. It prefers UK large-cap domestic banks over UK international stocks like HSBC and Standard Chartered despite the ongoing uncertainty over Brexit.

Last year, UK bank shares fell between 16-26% but they still outperformed European banks.

“Part of this was a narrowing of the 'Brexit discount' (we estimate this is currently 15% vs a peak of 20%) but it also reflects, we believe, better fundamentals in the UK (customer NIM remains far more stable in the UK than in the Eurozone),” Deutsche Bank said.

Deutsche Bank cuts target price on Standard Chartered

With that in mind, Deutsche Bank maintained a ‘hold’ rating on Standard Chartered but cut its target price to 580p from 620p, sending its shares down 1.3% to 608p.

“As with HSBC, we see some pressures emerging on revenue expectations due to the recent move in US rates,” it said.

“However, we think expectations for Standard Chartered are likely lower, reflecting the recent weaker operational performance.”

The investment bank said Standard Chartered has excess capital of around US$2.5bn but thinks management will use this to invest in growth or an upgrade of its systems to drive an improvement in returns as returning it to shareholders “won’t solve the return on tangible equity problem” it faces. HSBC could pay a share buyback in 2018 but Deutsche Bank thinks this is more likely in 2020. It expects US$1bn in share buybacks in 2020 and 2021.

Quick facts: HSBC

Price: 580.7 GBX

Market: LSE
Market Cap: £117.64 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Admedus Ltd proud to unveil its valves publicly for the first time in London

Admedus Ltd's (ASX:AHZ) CEO Wayne Paterson caught up with Proactive's Andrew Scott while in London. The firm recently made what's been described as a transformational move to sell off its CardioCel® and VascuCel® patch business. Paterson says the focus is now firmly on the Adapt...

15 hours, 10 minutes ago


Holding(s) in Company

1 day, 14 hours ago

Holding(s) in Company

1 day, 19 hours ago

Holding(s) in Company

4 days, 14 hours ago

Director/PDMR Shareholding

1 week, 1 day ago

Scrip Dividend - Exchange Rate

1 week, 2 days ago

Holding(s) in Company

1 week, 5 days ago

3 min read